Ads
related to: pharmaceuticals
Search results
Prediction: This Big-Box Retailer Will Follow Walmart and Split Its Stock in 2024
Motley Fool via Yahoo Finance· 23 hours agoThe stock market is roaring so far in 2024. Both the Nasdaq Composite and S&P 500 have gained...
Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, Chief Pharmaceutical ... By...
Investing.com· 4 days agoOn May 21, 2024, Robert Waltermire, Senior Vice President and Chief Pharmaceutical Development...
Taro Shareholders Approve Merger with Sun Pharma
KTLA-TV Los Angeles· 4 days agoSun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associates referred as "Sun ...
Avadel Pharmaceuticals appoints new board member By Investing.com
Investing.com· 6 days agoNaseem Amin to its board of directors, effective last Thursday. Dr. Amin, who currently serves as...
Pharma stock jumps 8% after company’s net profit increased by 57% YoY
Investing.com· 9 hours agoFollowing the release of FY24 financial results, which showed a growth in the net profit by 57...
Is It Too Late to Buy Vertex Pharmaceuticals Stock? | The Motley Fool
The Motley Fool· 24 hours agoVertex Pharmaceuticals (VRTX 1.36%) is a fast-growing pharmaceutical company that investors have...
Why Is Citius Pharmaceuticals (CTXR) Stock Up 11% Today?
InvestorPlace· 6 days agoCitius Pharmaceuticals (NASDAQ:CTXR) stock is on the rise Tuesday after the company announced new...
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
Zacks via Yahoo Finance· 2 hours agoThe S&P 500 Index has risen 11.6% in the same time frame. Cencora is one of the world’s largest ...
3 German firms considering PHL expansions, PEZA says - BusinessWorld Online
BusinessWorld· 21 hours agoTHE Philippine Economic Zone Authority (PEZA) said three German companies in the automotive, semiconductor, and pharmaceutical industries are planning to expand their Philippine ...
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Reaffirmed by JPMorgan Chase & Co.
ETF DAILY NEWS· 4 days agoSyndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at JPMorgan Chase & Co. in a note issued to investors ...